Managing HTAD: Key Insights from the 2024 ESC Guidelines 1:07:34-1:10:43 Q: Is the use of ARBs recommended in Marfan patients whose blood pressure is normal to low and this person has a abdominal aneurysm which is followed annually and the…

Managing HTAD: Key Insights from the 2024 ESC Guidelines 1:05:34-1:07:24 Q: What’s the difference between a Type B and a Type A dissection and how is it related to pregnancy? A型解離とB型解離の違いについて教えてください。また、妊娠との関係…

Managing HTAD: Key Insights from the 2024 ESC Guidelines 1:03:09-1:05:28 Q: Are there side effects that come from losartan? Julie? ロサルタンの副作用はありますか？ A: Yeah, I can go on. Side effects from the main... the main concern is tha…

Managing HTAD: Key Insights from the 2024 ESC Guidelines 59:57-1:03:02 Q: There is a question here about Celiprolol not being available in the United States, but currently, you can go into a trial with Celiprolol within the United States. …

Managing HTAD: Key Insights from the 2024 ESC Guidelines 57:36-59:55 Q: This family has genetic testing and they are in the VUS category, but they have been affected by aortic aneurysm for three generations, having, aortic aneurysm repair …

Managing HTAD: Key Insights from the 2024 ESC Guidelines 53:52-57:21 Q: Can you speak to the pros and cons of MRA versus gated CT for measurements of the aortic root in LDS or whether there is a case for both, for both tests in surveillanc…

Managing HTAD: Key Insights from the 2024 ESC Guidelines 51:58-53:39 Q: For ascending aortic aneurysms, do the ESC guidelines take us back from as 5 cm threshold for high-volume regional centers towards 5.5 cm as a recommended threshold, e…

Managing HTAD: Key Insights from the 2024 ESC Guidelines 45:34-51:49 Q: So this patient is a newly diagnosed with vEDS at 51 years of age and she's asking whether the condition lies dormant or has she had it since birth because she didn't …

Managing HTAD: Key Insights from the 2024 ESC Guidelines 43:29-44:19 I'm looking at physical activity. It is recommended to individualize physical activity. It used to be discouraged; however, we see that in patients with connective tissue…

Managing HTAD: Key Insights from the 2024 ESC Guidelines 42:12-43:27 Furthermore, for medical therapy, we advise Losartan, and why is this the case? This was a study done already in 2006, where it was shown that in mice, if you look at the…

Managing HTAD: Key Insights from the 2024 ESC Guidelines 38:04-42:10 And you can see this in our guidelines. So surgery is indeed indicated in patients with Marfan syndrome who have aortic root disease with a diameter of 50 millimeters. Th…

Managing HTAD: Key Insights from the 2024 ESC Guidelines 33:45-38:03 So first I would like to share some differences between Marfan syndrome, Loeys-Dietz syndrome and Ehlers-Danlos syndrome, which I will get back to later. 私からはまず、MF…

Managing HTAD: Key Insights from the 2024 ESC Guidelines 29:24-32:57 To end, I would like to spend a few words on pregnancy because we also have some recommendations there. Data on pregnancy and heritable thoracic aortic disease so far hav…